Vulvar pain: The revealing scenario of leading comorbidities in 1183 cases



      This study set out to investigate the epidemiological characteristics and comorbidities of chronic vulvar pain. Secondary goals were to identify the preferred approaches for managing vulvodynia in Italy.

      Study Design

      A cross-sectional study (the VuNet -Vulvodynia Network project) was performed in consecutive female patients with chronic vulvar pain attending 21 Italian medical centers (public hospitals, university clinics and private outpatient services) in the period December 2016 to November 2018. Study data were entered by healthcare professionals in a special web-based medical record system (PRIDE- Progetto Rete Italiana Dolore vulvarE). These data covered epidemiological aspects, demographic characteristics, obstetric and gynecological history, presence and duration of current and/or past symptoms, associated disorders, details of physical examination and treatment approaches.


      A total of 1183 subjects with a diagnosis of chronic vulvar pain were included in the study. The main reason for consultation was superficial dyspareunia, present in 64.2 % of the women. 43.4 % of the sample reported comorbid sexual disorders (of desire in 22.1 % and arousal in 21.3 %). 48.3 % of the patients reported prolonged pain lasting between one and five years. Factors associated with vulvar pain included a relatively high family history of diabetes mellitus (father = 8.6 %; mother = 8.4 %), recurrent vulvovaginal candidiasis (32 %), and urinary tract infections (37.4 %: recurrent cystitis in 19.5 % and post-coital cystitis in 17.9 %). Irritable bowel syndrome (28 %), constipation (23.5 %), headache (25.7 %: migraine in 18.0 % and menstrual headache in 7.7 %), allergies (17.5 %: food allergies in 10.1 %, respiratory allergies in 7.4 %), anxiety (15.0 %), dyschezia (11.7 %), invalidating dysmenorrhea/endometriosis (11.1 %), and major depression (7.6 %) were also reported. Vestibulodynia was diagnosed in 837 of the 1183 patients (70.8 %) and generalized vulvodynia in 323 (27.3 %). Notably, 69.1 % of the patients stated that previous therapies had not changed their pain.


      The diagnoses of vestibulodynia and vulvodynia must be considered in patients with chronic vulvar pain. The VuNet study contributes to a more comprehensive reading of the predisposing, precipitating and maintaining factors that contribute to vulvar pain, and of the key comorbidities.


      To read this article in full you will need to make a payment


        • Harlow B.L.
        • Stewart E.G.
        A population-based assessment of chronic unexplained vulvar pain: have we underestimated the prevalence of vulvodynia?.
        J Am Med Womens Assoc. 2003; 58: 82-88
        • Bornstein J.
        • Goldstein A.T.
        • Stockdale C.K.
        • et al.
        Consensus vulvar pain terminology committee of the International Society for the Study of Vulvovaginal Disease (ISSVD), the International Society for the Study of Womenʼs Sexual Health (ISSWSH), and the International Pelvic Pain Society (IPPS). 2015 ISSVD, ISSWSH and IPPS Consensus terminology and classification of persistent vulvar pain and vulvodynia.
        J Low Genit Tract Dis. 2016; : 126-130
      1. Graziottin A. Murina F. Vulvar pain: from childhood to Old age. Springer International Publishing, 2017
        • Moyal-Barracco M.
        • Lynch P.
        ISSVD terminology and classification vulvodynia: a historical perspective.
        J Reprod Med. 2003; 2004: 772-777
        • Graziottin A.
        Recurrent cystitis after intercourse: why the gynaecologist has a say.
        in: Current progress in obstetrics and gynaecology. vol. 2. Suketu P. Kothari - TreeLife Media, Mumbai, India2014 (p. 319)
        • Pukall C.F.
        • Goldstein A.T.
        • Bergeron S.
        • et al.
        Vulvodynia: definition, prevalence, impact, and pathophysiological factors.
        J Sex Med. 2016; 13: 291-304
        • Harlow B.L.
        • Kunitz C.G.
        • Nguyen R.H.
        • Rydell S.A.
        • Turner R.M.
        • MacLehose R.F.
        Prevalence of symptoms consistent with a diagnosis of vulvodynia: population-based estimates from 2 geographic regions.
        Am J Obstet Gynecol. 2014; 210: e1-e8
        • Reed B.D.
        • Legocki L.J.
        • Plegue M.A.
        • Sen A.
        • Haefner H.K.
        • Harlow S.D.
        Factors associated with vulvodynia incidence.
        Obstet Gynecol. 2014; 123: 225-231
        • Lev-Sagie A.
        • Prus D.
        • Linhares I.M.
        • Lavy Y.
        • Ledger W.J.
        • Witkin S.S.
        Polymorphism in a gene coding for the inflammasome component NALP3 and recurrent vulvovaginal candidiasis in women with vulvar vestibulitis syndrome.
        Am J Obstet Gynecol. 2009; 200: e1-e6
        • Gerber S.
        • Bongiovanni A.M.
        • Ledger W.J.
        • Witkin S.S.
        Interleukin-1beta gene polymorphism in women with vulvar vestibulitis syndrome.
        Eur J Obstet Gynecol Reprod Biol. 2003; 107: 74-77
        • Akopians A.L.
        • Rapkin A.J.
        Vulvodynia: the role of inflammation in the etiology of localized provoked pain of the vulvar vestibule (vestibulodynia).
        Semin Reprod Med. 2015; 33: 239-245
      2. ISTAT 2017. Available from:

        • De Leon E.M.
        • Jacober S.J.
        • Sobel J.D.
        • Foxman B.
        Prevalence and risk factors for vaginal Candida colonization in women with type 1 and type 2 diabetes.
        BMC Infect Dis. 2002; : 2
        • Murina F.
        • Vicariotto F.
        • Di Francesco S.
        Thymol, eugenol and lactobacilli in a medical device for the treatment of bacterial vaginosis and vulvovaginal candidiasis.
        New Microbiol. 2018; 41: 220-224
        • Graziottin A.
        • Gambini D.
        • Bertolasi L.
        Genital and sexual pain in women.
        in: Vodusek D. Boller F. neurology of sexual and bladder disorders (handbook of clinical neurology, volume 130, 3rd series). Elsevier, 2015: 395-412
        • Malykhina A.P.
        Neural mechanisms of pelvic organ cross-sensitization.
        Neuroscience. 2007; 149: 660-672
        • Khandker M.
        • Brady S.S.
        • Vitonis A.F.
        • Maclehose R.F.
        • Stewart E.G.
        • Harlow B.L.
        The influence of depression and anxiety on risk of adult onset vulvodynia.
        J Womens Health (Larchmt). 2011; 20: 1445-1451
        • Payne K.A.
        • Binik Y.M.
        • Amsel R.
        • Khalifé S.
        When sex hurts, anxiety and fear orient attention towards pain.
        Eur J Pain. 2005; 9: 427-436
        • Turk D.C.
        • Fillingim R.B.
        • Ohrbach R.
        • Patel K.V.
        Assessment of psychosocial and functional impact of chronic pain.
        J Pain. 2016; 17: T21-T49
        • Lamvu G.
        • Alappattu M.
        • Witzeman K.
        • Bishop M.
        • Robinson M.
        • Rapkin A.
        Patterns in vulvodynia treatments and 6-Month outcomes for women enrolled in the national vulvodynia registry-an exploratory prospective study.
        J Sex Med. 2018; 15: 705-715